BERGMANN ANDREAS has a total of 42 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets measurement, pharmaceuticals and biotechnology are STRUCK JOACHIM, BRAHMS AG and SPHINGOTEC GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 34 | |
#2 | WIPO (World Intellectual Property Organization) | 8 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Basic communication technologies |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Unspecified technologies | |
#6 | Resonators | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Bergmann Andreas | 42 |
#2 | Struck Joachim | 28 |
#3 | Papassotiriou Jana | 9 |
#4 | Morgenthaler Nils | 8 |
#5 | Morgenthaler Nils G | 5 |
#6 | Ernst Andrea | 4 |
#7 | Mueller Beat | 2 |
#8 | Ng Leong L | 2 |
#9 | Hartmann Oliver | 2 |
#10 | Wegloehner Wolfgang | 2 |
Publication | Filing date | Title |
---|---|---|
US2012082998A1 | Detection of bacterial infections in subjects suffering from dyspnea | |
US2012142120A1 | Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunction | |
US2009191220A1 | Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists | |
US2010209433A1 | Methods of treatment using ADM antibodies |